Long Noncoding RNAs MALAT1 and ANRIL Gene Variants and the Risk of Cerebral Ischemic Stroke: An Association Study
- 5 April 2021
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Chemical Neuroscience
- Vol. 12 (8) , 1351-1362
Abstract
Cerebral ischemic stroke (CIS) is one of the primary causes of death worldwide and a major cause of long-term disability. Long noncoding RNAs (lncRNAs) have emerged as crucial mediators in the pathology of CIS; however, their potential importance is yet to be discovered. Herein, we examined the association of four single-nucleotide polymorphisms (SNPs) with the risk of CIS, their correlation with the lncRNAs, MALAT1 and ANRIL, expression, and the potential of serum MALAT1 and ANRIL as biomarkers for CIS. A total of 100 CIS patients and 100 healthy controls were recruited in the study. Genotyping and expression analysis of MALAT1 and ANRIL SNPs were carried out by qPCR. The present results showed that serum MALAT1 was downregulated, while serum ANRIL was overexpressed in CIS patients, relative to controls. MALAT1 downregulation discriminated CIS patients from controls by receiver-operating-characteristic analysis. Moreover, serum ANRIL denoted good diagnostic accuracy. MALAT1 rs619586 AA and rs3200401 CT, TT were associated with increased CIS risk, whereas ANRIL rs10965215 GG was found to be protective. The studied ANRIL rs10738605 polymorphism was not associated with CIS susceptibility. Notably, the G variant of MALAT1 rs619586 demonstrated a higher serum MALAT1 expression level. Multivariate logistic regression analysis revealed serum MALAT1 as well as MALAT1 rs3200401 CT + TT as independent predictors of CIS. Additionally, a negative association was found between the serum MALAT1 level and the National Institutes of Health Stroke Scale score. In conclusion, MALAT1 rs619586 and rs3200401 and ANRIL rs10965215 are novel prospective noninvasive diagnostic biomarkers for CIS predisposition.Keywords
This publication has 66 references indexed in Scilit:
- Pathophysiology of Long Non-coding RNAs in Ischemic StrokeFrontiers in Molecular Neuroscience, 2018
- Long non-coding RNAs in ischemic strokeCell Death & Disease, 2018
- Altered Expression of Long Noncoding RNAs in Blood After Ischemic Stroke and Proximity to Putative Stroke Risk LociStroke, 2016
- The epidemiology of stroke in the Middle EastEuropean Stroke Journal, 2016
- Emerging epigenetic mechanisms of long non-coding RNAsNeuroscience, 2014
- Long non-coding RNAs: new players in cell differentiation and developmentNature Reviews Genetics, 2013
- Posttranscriptional Gene Regulation by Long Noncoding RNAJournal of Molecular Biology, 2013
- Epigenetic modifications in cardiovascular diseaseBasic Research in Cardiology, 2012
- Long noncoding RNAs and human diseaseTrends in Cell Biology, 2011
- Cardiorenal SyndromeJACC, 2008